January 11, 2018 Uncategorized

First imaging agent of its kind now approved in Canada to help physicians in the diagnosis of patients with suspected Parkinsonian Syndromes

CHALFONT ST. GILES, UK, 11 January 2018 – GE Healthcare announced today the approval in Canada of DaTscan™ (Ioflupane I 123 Injection), the first Health Canada approved radiopharmaceutical adjunct imaging agent to help physicians evaluate patients with a suspected parkinsonian syndrome (PS) such as https://www.genewsroom.com/press-releases/first-imaging-agent-its-kind-now-approved-canada-help-physicians-diagnosis-patients Read more

January 8, 2018 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment

Chicago, USA Jan 8, 2018 – GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients. The two companies... Read more

December 18, 2017 Product Launch

Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years

PROVIDENCE, R.I. (December 12, 2017) – Lifespan and GE Healthcare announced today a commitment to improving health care delivery in the Rhode Island region for patients, health care providers and the community. The goal of the collaboration is to increase capacity within the health system while reducing the cost of care. The agreement targets $182 million... Read more

November 28, 2017 Uncategorized

A message to our Customers

GE Healthcare’s priority is to provide safe products that help improve patient health. Recent publications indicate low levels of gadolinium are retained in the brain following repeated exposure to gadolinium-based contrast agents (GBCAs). We take very seriously any information concerning possible https://www.genewsroom.com/press-releases/message-our-customers Read more

November 24, 2017 M&A, Partnerships

GE Healthcare acquires bioprocessing start-up Puridify

Chalfont St Giles, UK – 28 November 2017 – GE Healthcare has completed the acquisition of Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify’s technology, FibroSelect, is complementary to the bead resins and chromatography membranes used today in downstream bioprocessing, promising faster mass transfer, scalability and ease... Read more

October 18, 2017 PR/Corporate

GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology

GE Healthcare today announced that it has received Carequality certification to enable seamless data sharing by its ambulatory EHR customers with thousands of hospitals, physician practices, payer networks, vendors and consumer services nationally. Already a KLAS top performer for interoperability impact on patient care1, GE Healthcare built upon its existing expertise in providing digital tools... Read more

October 11, 2017 Uncategorized

GE Healthcare & Shirazi Trading introduce imaging technologies to empower Pakistan’s Radiologists

PAKISTAN, Lahore, October 4th, 2017: GE (NYSE: GE) and Shirazi Trading, distributors of hospital equipment including diagnostic imaging systems, today kicked-off a three-day series of Cardiac CT & MR workshops in Pakistan, which convened cardiologists and radiologists from Karachi, Lahore, Islamabad, Multan, Peshawar, Bahawalpur and Faisalabad. Dr. Saima Mushtaq, a renowned leader in the field... Read more

October 11, 2017 Uncategorized

GE Healthcare & Shirazi Trading introduce imaging technologies to empower Pakistan’s Radiologists

PAKISTAN, Lahore, October 4th, 2017: GE (NYSE: GE) and Shirazi Trading, distributors of hospital equipment including diagnostic imaging systems, today kicked-off a three-day series of Cardiac CT & MR workshops in Pakistan, which convened cardiologists and radiologists from Karachi, Lahore, https://www.genewsroom.com/press-releases/ge-healthcare-shirazi-trading-introduce-imaging-technologies-empower-pakistans Read more

September 22, 2017 Product Launch

GE sets new standard for monoclonal antibody purification: Up to 40% increase in capacity

CHALFONT ST. GILES, UK and UPPSALA, SWEDEN – 25 September 2017 – GE Healthcare introduces a new Protein A chromatography resin, MabSelect PrismA, which will help biopharmaceutical manufacturers improve their monoclonal antibody (mAb) purification capacity by up to 40 percent (1). The resin is also significantly more alkaline-stable (2), meaning that MabSelect PrismA can be... Read more